Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM9U7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,109
Award facts
- Contract value 100% obligated
- $24,109.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $24.1K to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pens on January 13, 2026, with an ultimate completion date of January 14, 2026. This is a firm fixed-price delivery order with no set-aside designation, competed on a full and open basis. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare systems.
This delivery order is executed under Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a single-award IDC valued at up to $999.9M through December 2026. The parent company holds primary responsibility for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The award of Zepbound, a GLP-1 receptor agonist used in diabetes and weight management, reflects the broader scope of endocrinology products supplied through this strategic vehicle to support the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FM9U7?
SPE2DR26FM9U7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FM9U7 worth?
The government has obligated $24,109 on SPE2DR26FM9U7.
Is contract SPE2DR26FM9U7 an order under another contract?
Yes. SPE2DR26FM9U7 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM9U7 competed?
The extent of competition for SPE2DR26FM9U7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award